# DLX6

## Overview
DLX6 is a gene that encodes the protein distal-less homeobox 6, a member of the homeodomain transcription factor family. This protein plays a pivotal role in embryonic development, particularly in the formation of craniofacial structures, limbs, and neural tissues. As a transcription factor, distal-less homeobox 6 is involved in regulating the expression of genes critical for skeletal development, including those in the Osx/Sp7 and Runx2 pathways, which are essential for osteoblast differentiation and bone mineral density (Levi2022DLX). The gene is expressed in the developing forebrain, craniofacial regions, and limbs, highlighting its importance in morphogenesis (Robledo2002The; Tan2021DLX). Mutations in DLX6 have been associated with developmental disorders such as split-hand/foot malformation, underscoring its clinical significance (Robledo2002The; Ullah2016A).

## Function
DLX6 is a member of the homeobox gene family, which encodes transcription factors crucial for embryonic development. It plays a significant role in craniofacial development, limb formation, and the differentiation of neural and skeletal tissues. DLX6, along with its closely related gene DLX5, is involved in the regulation of chondrocyte and osteoblast differentiation, which are essential for bone formation and maintenance. These genes are expressed in the developing forebrain, craniofacial regions, and limbs during embryogenesis, indicating their importance in the morphogenesis of these structures (Robledo2002The; Tan2021DLX).

DLX6 functions as a transcription factor, influencing the expression of genes involved in skeletal development. It is active in the nucleus, where it regulates the transcription of target genes necessary for developmental processes. The DLX5/6 gene pair is associated with the regulation of key pathways in osteogenesis, including the Osx/Sp7 and Runx2 pathways, which are critical for osteoblast differentiation and bone mineral density (Levi2022DLX). The expression of DLX6 is regulated by intergenic enhancers that allow coordinated spatiotemporal expression, ensuring proper development of craniofacial structures and limbs (Tan2021DLX).

## Clinical Significance
Mutations and alterations in the DLX6 gene are associated with several developmental disorders, most notably split-hand/foot malformation (SHFM). SHFM is characterized by missing central digits and claw-like distal extremities. The DLX6 gene, along with DLX5, is located on chromosome 7q21.3, a region linked to SHFM type 1 (SHFM1) (Robledo2002The; Levi2022DLX). A study identified a novel heterozygous intragenic sequence variant in DLX6, suggesting its role in autosomal dominant SHFM1 (Ullah2016A). 

DLX6 is also implicated in craniofacial and limb malformations due to its role in the morphogenesis of these structures. Inactivation of DLX6, along with DLX5, in mice results in limb phenotypes similar to SHFM1, indicating the gene's involvement in limb development (Levi2022DLX). 

Additionally, DLX6 has been linked to bone mineral density (BMD) regulation. Genome-wide association studies have identified single nucleotide polymorphisms (SNPs) in the DLX5/6 region associated with BMD and osteoporosis susceptibility, suggesting that variations affecting DLX6 expression may influence these conditions (Levi2022DLX).

## Interactions
DLX6 is a homeodomain transcription factor that plays a significant role in developmental processes, particularly in the embryonic forebrain and limb development. While specific physical interactions of DLX6 with other proteins or nucleic acids are not extensively detailed, it is known to be involved in regulatory networks with other Dlx family members. DLX6, along with DLX5, is implicated in the regulation of Msx2 expression during limb development. This regulation is part of a non-cell-autonomous loop involving BMP signaling, where DLX5 and DLX6 control Msx2 expression in the apical ectodermal ridge (AER) and limb mesoderm (VieuxRochas2013BMPMediated).

DLX6 is also part of a cross-regulatory network with other Dlx genes, such as Dlx1 and Dlx2, which are crucial for its expression in the embryonic forebrain. These interactions are mediated through conserved intergenic enhancer sequences between Dlx5 and Dlx6, suggesting potential protein-DNA interactions (Zerucha2000A). Although specific binding interactions of DLX6 itself are not detailed, the regulatory role of Dlx proteins in these contexts implies that DLX6 may participate in similar interactions.


## References


[1. (VieuxRochas2013BMPMediated) Maxence Vieux-Rochas, Kamal Bouhali, Stefano Mantero, Giulia Garaffo, Paolo Provero, Simonetta Astigiano, Ottavia Barbieri, Mariano F. Caratozzolo, Apollonia Tullo, Luisa Guerrini, Yvan Lallemand, Benoît Robert, Giovanni Levi, and Giorgio R. Merlo. Bmp-mediated functional cooperation between dlx5;dlx6 and msx1;msx2 during mammalian limb development. PLoS ONE, 8(1):e51700, January 2013. URL: http://dx.doi.org/10.1371/journal.pone.0051700, doi:10.1371/journal.pone.0051700. This article has 28 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0051700)

[2. (Zerucha2000A) Ted Zerucha, Thorsten Stühmer, Gary Hatch, Byung K. Park, Qiaoming Long, Guoying Yu, Adrianna Gambarotta, Joshua R. Schultz, John L. R. Rubenstein, and Marc Ekker. A highly conserved enhancer in thedlx5/dlx6intergenic region is the site of cross-regulatory interactions betweendlxgenes in the embryonic forebrain. The Journal of Neuroscience, 20(2):709–721, January 2000. URL: http://dx.doi.org/10.1523/JNEUROSCI.20-02-00709.2000, doi:10.1523/jneurosci.20-02-00709.2000. This article has 409 citations.](https://doi.org/10.1523/JNEUROSCI.20-02-00709.2000)

[3. (Levi2022DLX) Giovanni Levi, Nicolas Narboux-Nême, and Martine Cohen-Solal. Dlx genes in the development and maintenance of the vertebrate skeleton: implications for human pathologies. Cells, 11(20):3277, October 2022. URL: http://dx.doi.org/10.3390/cells11203277, doi:10.3390/cells11203277. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cells11203277)

[4. (Tan2021DLX) Yinfei Tan and Joseph R. Testa. Dlx genes: roles in development and cancer. Cancers, 13(12):3005, June 2021. URL: http://dx.doi.org/10.3390/cancers13123005, doi:10.3390/cancers13123005. This article has 31 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers13123005)

[5. (Robledo2002The) Raymond F. Robledo, Lakshmi Rajan, Xue Li, and Thomas Lufkin. The dlx5 and dlx6 homeobox genes are essential for craniofacial, axial, and appendicular skeletal development. Genes &amp; Development, 16(9):1089–1101, May 2002. URL: http://dx.doi.org/10.1101/gad.988402, doi:10.1101/gad.988402. This article has 341 citations.](https://doi.org/10.1101/gad.988402)

[6. (Ullah2016A) Asmat Ullah, Anam Hammid, Muhammad Umair, and Wasim Ahmad. A novel heterozygous intragenic sequence variant in dlx6 probably underlies first case of autosomal dominant split-hand/foot malformation type 1. Molecular Syndromology, 8(2):79–84, December 2016. URL: http://dx.doi.org/10.1159/000453350, doi:10.1159/000453350. This article has 23 citations and is from a peer-reviewed journal.](https://doi.org/10.1159/000453350)